Infectious Diseases News and Research

RSS

Breathprints identify lung infections in mice

Researchers working with a mouse model have developed a technique for creating “breathprints” that flag up whether or not the animals have a lung infection.

25 Jan 2013

Tailored treatments and PSA screenings required to improve health outcomes in Ghana

Infectious diseases in Ghana tend to capture the most attention, but a quiet crisis may soon take over as the country's most threatening epidemic: cancer.

25 Jan 2013

Pediatric rotavirus vaccination indirectly protects unvaccinated adults

Pediatric rotavirus vaccination also indirectly protects unvaccinated adults from the highly contagious cause of severe diarrhea and vomiting, suggests a new study published in Clinical Infectious Diseases and available online.

25 Jan 2013

Voluntary moratorium on H5N1 research ends; fate of U.S.-funded research unknown

"Almost a year after they announced it, leading influenza researchers are ending a voluntary moratorium on certain types of controversial experiments involving the H5N1 avian influenza virus."

25 Jan 2013

CDC recognizes Mayo Clinic as Regional TB Training and Medical Consultation Center

Mayo Clinic has been designated a Regional Tuberculosis Training and Medical Consultation Center by the Centers for Disease Control and Prevention (CDC). As such, it will be responsible for developing new and enhanced training and technical support for medical and public health professionals in an 11-state area.

25 Jan 2013

Study highlights the need for more targeted antibiotic therapy in cancer patients

What cancerous conditions lead to what kinds of bacterial infections? If doctors knew, they could predict which patients would likely benefit from pre-treatment with certain kinds of antibiotics.

25 Jan 2013

Institute of Bioengineering and Nanotechnology, IBM reveal new antimicrobial hydrogel

Researchers from IBM and the Institute of Bioengineering and Nanotechnology revealed today an antimicrobial hydrogel that can break through diseased biofilms and completely eradicate drug-resistant bacteria upon contact.

24 Jan 2013

NIH's candidate vaccine safe in treating dengue

A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.

23 Jan 2013

Salk Institute to establish Helmsley Center for Genomic Medicine

The Salk Institute for Biological Studies has received a $42 million gift-the largest in the Institute's history-to establish the Helmsley Center for Genomic Medicine (HCGM), a research center dedicated to decoding the common genetic factors underlying many complex chronic human diseases.

23 Jan 2013

International community must harness funds needed to control infectious diseases

"I think the most special thing about our current time is the incredible opportunity that scientific advances have provided in the field of global health, giving us the ability to completely control highly dangerous infectious diseases such as AIDS, tuberculosis and malaria," Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, writes in an opinion piece in the Huffington Post's "The Big Push" blog.

23 Jan 2013

Antibodies essential for dendritic cell maturation

Dendritic cells, or DCs for short, perform a vital role for the immune system: They engulf pathogens, break them down into their component parts, and then display the pieces on their surface.

23 Jan 2013

Less is more for emergency department treatment of whiplash

Researchers recommend that patients presenting to emergency departments with acute whiplash should receive usual consultations and a single physiotherapy advice session for persistent symptoms.

22 Jan 2013

Low-income groups slow to seek treatment for stroke

People with lower incomes are less likely to present at a hospital within 3 hours of stroke symptoms and thus have lower rates of thrombolysis therapy or post-stroke care than their more affluent counterparts, according to a retrospective analysis.

22 Jan 2013

Simulation ticks box for checklists in surgical care

The management of operating-room crises could be significantly improved by using checklists, say researchers in the New England Journal of Medicine.

22 Jan 2013

Routine gastric volume monitoring thrown out

Monitoring gastric residual volumes in critically ill patients receiving enteral nutrition does not prevent them from developing ventilator-associated pneumonia, shows a randomized trial.

22 Jan 2013

PathCentral announces roll-out of new pathology network

PathCentral, a technology-enabled company dedicated to the success of the international pathology community, and China-based Kindstar Globalgene Technology, Inc., today announced the roll-out of the PathCentral Pathology Network, an online professional pathology network that will enable Kindstar to access US pathologists and facilitate pathology consultations for more than 3,300 hospitals throughout China.

22 Jan 2013

Simcere enters share transfer agreement with Devont Asset Management

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Company entered into a share transfer agreement with Devont Asset Management Limited on January 15th 2013 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co., Ltd. for a cash consideration of RMB 302 million.

22 Jan 2013

Studies suggest a new approach to treating HIV

A team of researchers based at Johns Hopkins has decoded a system that makes certain types of immune cells impervious to HIV infection.

22 Jan 2013

Scientists identify new mechanism that turns CD4 helper T lymphocytes into killer cells

A research team led by the La Jolla Institute for Allergy & Immunology has discovered the mechanism that enables CD4 helper T cells to assume the more aggressive role of killer T cells in mounting an immune attack against viruses, cancerous tumors and other damaged or infected cells.

21 Jan 2013

G-CON completes delivery and installation of POD system in PaxVax's GMP production facility

G-CON today announced the completed delivery and installation of the ground-breaking POD system in PaxVax's licensed GMP production facility based in San Diego, California where PaxVax manufactures innovative and socially responsible oral vaccines against infectious diseases.

19 Jan 2013

Infectious Diseases News and Research

Breathprints identify lung infections in mice

Tailored treatments and PSA screenings required to improve health outcomes in Ghana

Pediatric rotavirus vaccination indirectly protects unvaccinated adults

Voluntary moratorium on H5N1 research ends; fate of U.S.-funded research unknown

CDC recognizes Mayo Clinic as Regional TB Training and Medical Consultation Center

Study highlights the need for more targeted antibiotic therapy in cancer patients

Institute of Bioengineering and Nanotechnology, IBM reveal new antimicrobial hydrogel

NIH's candidate vaccine safe in treating dengue

Salk Institute to establish Helmsley Center for Genomic Medicine

International community must harness funds needed to control infectious diseases

Antibodies essential for dendritic cell maturation

Less is more for emergency department treatment of whiplash

Low-income groups slow to seek treatment for stroke

Simulation ticks box for checklists in surgical care

Routine gastric volume monitoring thrown out

PathCentral announces roll-out of new pathology network

Simcere enters share transfer agreement with Devont Asset Management

Studies suggest a new approach to treating HIV

Scientists identify new mechanism that turns CD4 helper T lymphocytes into killer cells

G-CON completes delivery and installation of POD system in PaxVax's GMP production facility

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News